Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 117565-57-8 | MDL No. : | MFCD08460961 |
Formula : | C12H21NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HGJKZGGZDSJORL-UHFFFAOYSA-N |
M.W : | 227.30 | Pubchem ID : | 22278903 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.83 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 66.41 |
TPSA : | 46.61 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.63 cm/s |
Log Po/w (iLOGP) : | 2.81 |
Log Po/w (XLOGP3) : | 1.49 |
Log Po/w (WLOGP) : | 1.84 |
Log Po/w (MLOGP) : | 1.33 |
Log Po/w (SILICOS-IT) : | 1.62 |
Consensus Log Po/w : | 1.82 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.92 |
Solubility : | 2.71 mg/ml ; 0.0119 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.08 |
Solubility : | 1.91 mg/ml ; 0.00839 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.96 |
Solubility : | 2.48 mg/ml ; 0.0109 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.68 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | Stage #1: With triethylamine In methanol; dichloromethane at 23℃; for 16 h; Stage #2: With sodium hydroxide In water |
Compound 26 (2.90 g, 10.2 mmol) was suspended in 6 N HCl (85 ml) and refluxed for 16 h. The product was concentrated and azeotroped three times with isopropanol to give a yellow solid. The solid was dissolved in 1:1 CH2Cl2:MeOH (50 ml) and Et3N (3.08 g, 4.3 ml, 30.5 mmol) and di-t-butyl dicarbonate (3.32 g, 15.2 mmol) were added. The mixture was stirred at 23° C. for 16 h, then concentrated. 0.5 N NaOH (50 ml) was added and the mixture extracted with CH2Cl2. The combined organic extracts were dried (MgSO4), filtered, and concentrated. Purification by silica gel chromatography (eluant: 10percent EtOAc-hexane) gave 1.92 g (8.46 mmol, 83percent) of the product 27A as a colorless oil. MS (ES for M+1): m/e 228 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
680 mg | With toluene-4-sulfonic acid In benzene for 16 h; Reflux | Step 1 A solution of 4-oxo-piperidine-1-carboxylic acid tert-butyl ester (5 g, 25.1 mmol), pyrolidine (5 mL) and p-toluenesulfonic acid (25 mg) in benzene (100 mL) was heated at reflux for 16 h with azeotropic distillation of water. The resulting enamine solution was cooled to rt and concentrated. The crude enamine was dissolved in acetonitrile (50 mL); iodoethane (4.67 g, 30.1 mmoL) was added and the mixture was heated at 100° C. for 0.5 h, cooled to rt and concentrated. The mixture was dissolved in ethyl acetate (200 mL), washed with 1 N hydrochloric acid, saturated aqueous sodium bicarbonate, and brine. The extract was dried over magnesium sulfate, filtered and concentrated. The crude compound was purified by silica gel chromatography (80percent hexanes/20percent ethyl acetate) to afford 3-ethyl-4-oxo-piperidine-1-carboxylic acid tert-butyl ester (680 mg). 1H-NMR (CDCl3, 300 MHz) δ: 0.95 (t, 3H), 1.26-1.42 (m, 1H), 1.50 (s, 9H), 1.69-1.85 (m, 1H), 2.30 (br s, 1H), 2.43 (q, 2H), 2.90-4.36 (m, 4H). |
[ 637301-19-0 ]
3-Boc-3-azabicyclo[3.2.1]octan-8-one
Similarity: 0.98
[ 181269-69-2 ]
tert-Butyl 3-methyl-4-oxopiperidine-1-carboxylate
Similarity: 0.98
[ 324769-06-4 ]
1-(tert-Butoxycarbonyl)-3,3-dimethyl-4-oxopiperidine
Similarity: 0.98
[ 879687-92-0 ]
tert-Butyl 4-oxohexahydro-1H-isoindole-2(3H)-carboxylate
Similarity: 0.96
[ 206989-61-9 ]
tert-Butyl 4-acetylpiperidine-1-carboxylate
Similarity: 0.96
[ 637301-19-0 ]
3-Boc-3-azabicyclo[3.2.1]octan-8-one
Similarity: 0.98
[ 181269-69-2 ]
tert-Butyl 3-methyl-4-oxopiperidine-1-carboxylate
Similarity: 0.98
[ 324769-06-4 ]
1-(tert-Butoxycarbonyl)-3,3-dimethyl-4-oxopiperidine
Similarity: 0.98
[ 879687-92-0 ]
tert-Butyl 4-oxohexahydro-1H-isoindole-2(3H)-carboxylate
Similarity: 0.96
[ 206989-61-9 ]
tert-Butyl 4-acetylpiperidine-1-carboxylate
Similarity: 0.96
[ 181269-69-2 ]
tert-Butyl 3-methyl-4-oxopiperidine-1-carboxylate
Similarity: 0.98
[ 324769-06-4 ]
1-(tert-Butoxycarbonyl)-3,3-dimethyl-4-oxopiperidine
Similarity: 0.98
[ 879687-92-0 ]
tert-Butyl 4-oxohexahydro-1H-isoindole-2(3H)-carboxylate
Similarity: 0.96
[ 118156-93-7 ]
tert-Butyl 3-formylpiperidine-1-carboxylate
Similarity: 0.96
[ 206989-61-9 ]
tert-Butyl 4-acetylpiperidine-1-carboxylate
Similarity: 0.96
[ 181269-69-2 ]
tert-Butyl 3-methyl-4-oxopiperidine-1-carboxylate
Similarity: 0.98
[ 324769-06-4 ]
1-(tert-Butoxycarbonyl)-3,3-dimethyl-4-oxopiperidine
Similarity: 0.98
[ 118156-93-7 ]
tert-Butyl 3-formylpiperidine-1-carboxylate
Similarity: 0.96
[ 206989-61-9 ]
tert-Butyl 4-acetylpiperidine-1-carboxylate
Similarity: 0.96
[ 419571-73-6 ]
tert-Butyl 4-propionylpiperidine-1-carboxylate
Similarity: 0.96